Form 4 for RMD ResMed|
Accepted 2022-11-15 00:00:00 ET · period of report 2022-11-11 · accession 0001127602-22-025659 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-11-15 | 2022-11-11 | RMD | Douglas Robert Andrew | Pres, COO | F - Tax | $225.18 | -1,705 | 34.2K | -5% | -$383.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2022-11-11 | F | D | 760 | $225.18 | 33,434 | D | — | — | (F3) Includes 52.908 shares of ResMed stock purchased on October 31, 2022, through the ResMed Employee Stock Purchase Plan. |
| 2 | Common | ResMed Common Stock | 2022-11-11 | F | D | 945 | $225.18 | 34,194 | D | — | — |